Summit Medical And Shippert Medical Unite Under New Brand: Innovia Medical, LLC

The new brand combines the expertise and experience of two leading medical device manufacturers

ST.PAUL, Minn.--(BUSINESS WIRE)--Shore Capital Partners is combining two medical device manufacturers under a new brand — Innovia Medical. Shore is a Chicago-based private equity firm focused exclusively on microcap health care investments and owner of the manufacturers Summit Medical and Shippert Medical.

Innovia Medical will continue to manufacture and market the full-range of Summit Medical and Shippert Medical products, including ear, nose and throat (ENT), Tissu-Trans®, InstruSafe® Instrument Protection Trays and Care + Maintenance Products, EarPopper® and Minne Ties® Agile MMF products. Product design, research, manufacturing, sales and customer service will continue to be based at the company’s St. Paul, MN and Denver, CO locations. Terry Meredith will serve as Chief Executive Officer of Innovia Medical, while Kevin McIntosh, President of Summit Medical, will continue to lead the St. Paul operations and Allison Therwhanger, President of Shippert Medical, will continue to lead the Colorado operations.

“Combining these two organizations is truly an example of the whole being greater than the sum of its parts,” said Innovia Medical CEO Terry Meredith. “These organizations offered complementary product lines and shared common business philosophies and expertise, focused on three areas: continuous innovation through close collaboration with our medical professional partners; a commitment to unrivaled product quality; and a dedication to provide the highest quality, personalized customer service in the markets we serve. By joining them together, Innovia Medical can leverage the combined resources and expertise to enhance our mission to be the trusted partner of medical professionals to help them provide the very best care possible.”

Learn more at innoviamedical.com.

Innovia Medical
Marcus Super, 651-789-3949
msuper@innoviamedical.com

Back to news